Progression of retinopathy in type 1 diabetic women during pregnancy

Current Diabetes Reviews

Volumn 3, Issue 2, 2007, Pages 85-93

  Kaaja, Risto ^a   Loukovaara, Sirpa ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Angiogenesis; Diabetic retinopathy; Pregnancy; Retinal blood flow; Type 1 diabetes; Vascular factors

Indexed keywords

ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GROWTH FACTOR; INSULIN; INSULIN LISPRO; PROTEIN KINASE C INHIBITOR; RUBOXISTAURIN; SOMATOSTATIN DERIVATIVE; STEROID;

ANTIANGIOGENIC GENE THERAPY; CARDIOVASCULAR DISEASE; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; FEMALE; FLUID RETENTION; HEMODYNAMICS; HUMAN; HYPERCOAGULABILITY; HYPERGLYCEMIA; HYPERVOLEMIA; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; LASER COAGULATION; NONHUMAN; PATHOGENESIS; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; PUERPERIUM; RETINA MACULA EDEMA; REVIEW; RISK FACTOR;

ANGIOGENIC PROTEINS; CARDIOVASCULAR PHYSIOLOGY; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; HEMODYNAMICS; HUMANS; INFLAMMATION; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; PREGNANCY; PREGNANCY IN DIABETICS; WATER-ELECTROLYTE IMBALANCE;

EID: 34248681039     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339907780598252     Document Type: Review

References (183)

1. Aiello LP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabetes Care 1998; 21: 143-56.
2. Gupta A, Gupta V. Diabetic blindness: a major challenge. J Indian Med Assoc 2000; 98: 772-75.
3. Klein BEK, Klein R. Gravidity and diabetic retinopathy. Am J Epidemiol 1984; 119: 564-69.
4. National Research and Development Centre for Welfare and Health in Finland, The Finnish Register of Visual Impairment 2001.
5. Elman KD, Welch RA, Frank RN, Goyert GL, Sokol RJ. Diabetic retinopathy in pregnancy: a review. Obstet Gynecol 1990; 75: 119-27.
6. Garner A. Histopathology of diabetic retinopathy in man. Eye 1993; 7: 250-53.
7. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1978; 1: 168-88.
8. Klein BEK, Moss SE, Klein R. Longitudinal measure of glycemic control and diabetic retinopathy. Diabetes Care 1987; 10: 273.
9. Kohner EM. Diabetic retinopathy. Br Med Bull 1989; 45: 148-73.
10. Archer DB. Diabetic retinopathy: some cellular, molecular and therapeutic considerations. Eye 1999; 13: 497-523.
11. Li W, Liu X, Yanoff M. Cohen S, Ye X. Cultural retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels: a comparative study with retinal capillary endothelial cells. Diabetologia 1996; 39: 537-47.
12. Mizuntani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 1996; 97: 2883-90.
13. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP. Leucocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 2001; 158: 147-52.
14. Lorenzi M, Gerhardinger C. Early cellular and molecular changes induced by diabetes in the retina. Diabetologia 2001; 44: 791-804.
15. Poulaki V, Qin W, Joussen AM, et al. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-lalpha and VEGF. J Clin Invest 2002; 109: 805-15.
16. Barnett AH. Origin of the microangiopathic changes in diabetes. Eye 1993; 7: 218-22.
17. Giugliano D, Paolisso G, Ceriello A. Oxidative Stress and Diabetic Vascular Complications. Diabetes Care 1996; 19: 257-67.
18. Stehouwer CD, Lambert J, Donker AJ, van Hinsbergh VW. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1977; 34: 55-68.
19. Funatsu H, Yamashita H. Pathophysiology of diabetic retinopathy. Drug News Perspect 2002; 15: 633-39.
20. Candido R, Allen TJ. Haemodynamics in microvascular complications in type I diabetes. Diabetes Metab Res Rev 2002; 18: 286-304.
21. Grammas P, Riden M. Retinal endothelial cells are more susceptible to oxidative stress and increased permeability than brain-derived endothelial cells. Microvasc Res 2003; 65: 18-23.
22. Patel V, Rassam S, Kohner E, Wiek J. Retinal blood flow in diabetic retinopathy. BMJ 1992; 305: 678-83.
23. Bursell SE, Clermont AC, Kinsley BT, Simonson DC, Aiello LM, Wolpert HA. Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Am J Physiol 1996; 270: R61-R70.
24. Clermont AC, Aiello LP, Mori F, Aiello LM, Bursell SE. Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol 1997; 124: 433-46.
25. Yoshida A, Feke GT, Moralles J. Retinal blood flow alterations during the progression of diabetic retinopathy. Arch Ophthalmol 1983; 101: 225-27.
26. Grunwald JE, Riva CE, Baine J, Brucker AJ. Total retinal volumetric blood flow rate in diabetic patients with poor glycemic control. Invest Ophthalmol Vis Sci 1992; 33: 356-63.
27. Kohner EM. The retinal blood flow in diabetes. Diabet Metab 1993; 19: 401-4.
28. Kohner EM, Patel V, Rassam S. Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 1995; 44: 603-7.
29. Risau W. Differentation of endothelium. FASEB J 1995; 9: 926-33.
30. Porta M. Endothelium: the main actor in the remodelling of the retinal microvasculature in diabetes. Diabetologia 1996; 39: 739-44.
31. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 2001; 22: 36-52.
32. Aird W. Endothelial cell heterogeneity. Crit Care Med 2003; 31: S221-30.
33. Wilkinson-Berka JL, Kelly DJ, Gilbert RE. The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes. J Vasc Res 2001; 38: 527-35.
34. Mäkimattila S, Summanen P, Matinlauri I, et al. Serum total renin, an independent marker of the activity and severity of retinopathy in patients with IDDM. Br J Ophthalmol 1998; 82: 939-44.
35. Engerman RL. Pathogenesis of diabetic retinopathy. Diabetes 1989; 38: 1203-6.
36. Robinson WG Jr, Nagata M, Laver N, Hohman TC, Kinoshita JH. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor. Invest Ophthalmol Vis Sci 1989; 30: 2285-92.
37. Schröder S, Palinski W, Schmid-Schönbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol 1991; 139: 81-100.
38. Stitt AW, Gardiner TA, Archer DB. Histological and ultrastructural. investigation of retinal microaneurysm development in diabetic patients. Br J Ophthalmol 1995; 79: 362-67.
39. Miyamoto K, Ogura Y, Kenmochi S, Honda Y. Role of leukocytes in diabetic microcirulatory disturbances. Microvasc Res 1997; 54: 43-8.
40. Forrester JV. Mechanisms of new vessel formation in the retina. Diabet Med 1987; 4: 423-30.
41. Merimee TJ, Zapf J, Froesch R. Insulin-like growth factors; studies in diabetics with and without retinopathy. N Engl J Med 1983; 309: 527-30.
42. Boulton M, Gregor Z, McLeod D, et al. Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management. Br J Ophthalmol 1997; 81: 228-33.
43. Boulton M, Foreman M, Williams G, McLeod D. VEGF localisation in diabetic retinopathy. Br J Ophthalmol 1998; 82: 561-68.
44. Cai J, Boulton M. The pathogenesis of diabetic retinopathy. Eye 2002; 16: 242-60.
45. Witmer AN, Vrensen GFJM, Van Noorden CJF, Schlingemann RO. Vascular endothelial growth factors and angiogenesis in eye disease. Progress in Retinal and Eye Research 2003; 22: 1-29.
46. Adamis AP. Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol 2002; 86: 363-5.
47. Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW. Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 2002; 47 (Suppl 2): S253-62.
48. Gearing AJH, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, VCAM-1: pathological significance. Ann NY Acad Sci 1992; 667: 324-31.
49. Ruggiero D, Lecomte M, Michoud E, Lagarde M, Wiernsperger N. Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy. Diabetes Metab 1997; 23: 30-42.
50. Ewing FME, Deary IJ, Strachan MWJ, Frier BM. Seeing beyond retinopathy in diabetes: Electrophysiological and psychophysical abnormalities and alterations in vision. Endocr Rev 1998; 19: 462-76.
51. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 283-90.
52. Khosla PK, Talwar D, Tewari HK. Contrast sensitivity changes in background diabetic retinopathy. Can J Ophthalmol 1991; 26: 7-11.
53. di Leo MAS, Caputo S, Falsini B, et al. Nonselective loss of contrast sensitivity in visual system testing in early type I diabetes. Diabetes Care 1992; 15: 620-5.
54. Hellstedt T, Kaaja R, Teramo K, Immonen I. Contrast sensitivity in diabetic pregnancy. Graefes Arch Clin Exp Ophthalmol 1997; 235: 70-5.
55. Ghafour IM, Foulds WS, Allan D, McClure E. Contrast sensitivity in diabetic subjects with and without retinopathy. Br J Ophthalmol 1982; 66: 492-95.
56. Banford D, North RV, Dolben J, Butler G, Owens DR. Longitudinal study of visual functions in young insulin dependent diabetics. Ophthal Physiol Opt 1994; 14: 339-46.
57. Lopes de Faria JM, Russ H, Costa VP. Retinal nerve fibre layer loss in patients with type 1 diabetes mellitus without retinopathy. Br J Ophthalmol. 2002; 86: 725-28.
58. Fong DS. Changing times for the management of diabetic retinopathy. Surv Ophthalmol 2002; 47(Suppl 2): S238-S245.
59. Jialal I, Devaraj S, Venugopal SK. Oxidative stress, inflammation, and diabetic vasculopathies: the role of alpha tocopherol therapy. Free Radic Res 2002; 36: 1331-36.
60. Frank RN. Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors. Am J Ophthalmol 2002; 133: 693-98.
61. Grant M, Caballero S. Somatostatin analogues as drug therapies for retinopathies. Drugs Today (Barc) 2002; 38: 783-91.
62. Estafanous MFG, Kaiser PK, Bowen A. A posterior sub-tenons Kenalog injections in diabetic macular edema. Invest Ophthalmol Vis Sci 2000; 41: S115.
63. Jonas JB, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001; 132: 425-27.
64. Davidorf FH, Chambers RB. Diabetic retinopathy during pregnancy. Clin Perinatol 1993; 20: 571-81.
65. Gabbe ST. Pregnancy in women with diabetes mellitus. Clin Perinatol 1993; 20: 507-15.
66. Cousins L. Pregnancy complications among diabetic women: review 1965-1985. Obstet Gynecol Surv 1987; 42: 140-49.
67. Leinonen PJ, Hiilesmaa VK, Kaaja RJ, Teramo KA. Maternal mortality in type 1 diabetes. [Letters: Observations] Diabetes Care 2001; 24: 1501-2.
68. Engelgau MM, Herman WH, Smith PJ, German RR, Aubert RE. The epidemiology of diabetes and pregnancy in the U.S., 1988. Diabetes Care 1995; 18: 1029-33.
69. von Kries R, Kimmerle R, Schmidt JE, Hachmeister A, Bohm O, Wolf HG. Pregnancy outcomes in mothers with pregestational diabetes: a population-based study in North Rhine (Germany) from 1988 to 1993. Eur J Pediatr 1997; 156: 963-67.
70. Hawthorne G, Robson S, Ryall EAD Sen, Roberts SH, Platt MP. Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit,1994. BMJ 1997; 315: 279-81.
71. Hadden DR. How to improve prognosis in type I diabetic pregnancy. Diabetes Care 1999; 22 (Suppl. 2): B104-B108.
72. Price JH, Hadden DR, Archer DB, Harley JM. Diabetic retinopathy in pregnancy. Br J Obstet Gynaecol 1984; 91: 11-17.
73. Klein BE, Klein R, Meuer SM, Moss SE, Dalton DD. Does the severity of diabetic retinopathy predict pregnancy outcome? J Diabet Complications 1988; 2: 179-84.
74. Kitzmiller JL, Buchanan TA, Kjos S, Combs CA, Ratner RE. Preconception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care 1996; 19: 514-41.
75. Star J, Carpenter MW. The effect of pregnancy on the natural history of diabetic retinopathy and nephropathy. Clin Perinatol 1998; 25: 887-916.
76. Jovanovic L. Medical emergencies in the patient with diabetes during pregnancy. Endocrinol Metab Clin North Am 2000; 29: 771-87.
77. Casson IF, Clarke CA, Howard CV, et al. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 1997; 315: 275-78.
78. Dunne FP, Brydon PA, Proffitt M, Smith T, Gee H, Holder RL. Fetal and maternal outcomes in Indo-Asian compared to Caucasian women with diabetes in pregnancy. QJM 2000; 93: 813-18.
79. White P. Pregnancy complicating diabetes. Am J Med 1949; 7: 609-16.
80. White P. Classification of obstetric diabetes. Am J Obstet Gynecol 1978; 130: 228-30.
81. McElvy SS, Demarini S, Miodovnik M, Khoury JC, Rosenn B, Tsang RC. Fetal weight and progression of diabetic retinopathy. Obstet Gynecol 2001; 97: 587-92.
82. Thornburg KL, Jacobson S-L, Giraud GD, Morton MJ. Hemodynamic changes in pregnancy. Semin Perinatol 2000; 24: 11-4.
83. Soubrane G, Canivet J, Coscas G. Influence of pregnancy on the evolution of background retinopathy: preliminary results of a prospective fluorescein angiography study. Int Ophthalmol 1985; 8: 249-55.
84. Reece EA, Homko CJ, Hagay Z. Diabetic retinopathy in pregnancy. Obstet Gynecol Clin North Am 1996; 23: 161-71.
85. Laatikainen L, Larinkari J, Teramo K, Raivio KO. Occurence and prognostic signifigance of retinopathy in diabetic pregnancy. Metab Pediatr Ophthalmol 1980; 4: 191-95.
86. Dibble CM, Kochenour NK, Worley RJ, Tyler FH, Swartz M. Effect of pregnancy on diabetic retinopathy. Obstet Gynecol 1982; 59: 699-704.
87. Moloney JBM, Drury MI. The effect of pregnancy on the natural course of diabetic retinopathy. Am J Ophthalmol 1982; 93: 745-56.
88. Serup L. Influence of pregnancy on diabetic retinopathy. Acta Endocrinol Suppl (Copenh.)1986: 277; 122-24.
89. Klein BEK, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care 1990; 13: 34-46.
90. Reece EA, Lockwood CJ, Tuck S, et al. Retinal and pregnancy outcomes in the presence of diabetic proliferative retinopathy. J Reproduct Med 1994; 39: 799-804.
91. Rosenn BM, Miodovnik M. Medical complications of diabetes mellitus in pregnancy. Clin Obstet Gynecol 2000; 43: 17-31.
92. Schannwell CM, Schneppenheim M, Perings SM, Zimmermann T, Plehn G, Strauer BE. Alterations of left ventricular function in women with insulin-dependent diabetes mellitus during pregnancy. Diabetologia 2003; 46: 267-75.
93. Bresnick GH. Diabetic macular edema. Ophthalmology 1986; 93: 989-97.
94. Yanoff M, Fine BS, Brucker AJ, et al. Pathology of human cystoid macular edema. Surv Ophthalmol 1984; 28: 505-11.
95. Yanoff M, Fine BS. Diabetes Mellitus. In: Yanoff M, Fine BS Ed, Ocular Pathology. London, Mosby-Wolfe 1996, 563-65.
96. Sokol S, Moskowitz A, Skarf B, Evans R, Molitch M, Senior B. Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol 1985; 103: 51-4.
97. Loukovaara S, Harju M, Kaaja R, Immonen I. Topographic change in the central macula coupled with contrast sensitivity loss in diabetic pregnancy. Graefes Arch Clin Exp Ophthalmol 2003; 241: 607-614.
98. Duvekot JJ, Peeters LH. Maternal cardiovascular hemodynamic adaptation to pregnancy. Obstet Gynecol Surv 1994; 49(12 Suppl): S1-S14.
99. Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 1989; 256: H1060-65.
100. Friedman SA, Taylor RN, Roberts JM. Pathophysiology of preeclamspia. Clin Perinatol 1991; 18: 661-82.
101. Sunness JS. The pregnant woman's eye. Surv Ophthalmol 1988; 32: 219-38.
102. Ciulla TA, Harris A, Latkany P, et al. Ocular perfusion abnormalities in diabetes. Acta Ophthalmol Scand 2002; 80: 468-77.
103. Grunwald JE, DuPont J, Riva CE. Retinal haemodynamics in patients with early diabetes mellitus. Br J Ophthalmol 1996; 80: 327-31.
104. Chen HC, Newsom RSB, Patel V, Cassar J, Mather H, Kohner E. Retinal blood flow changes during pregnancy in women with diabetes. Invest Ophthalmol Vis Sci 1994; 35: 3199-208.
105. Hellstedt T, Kaaja R, Teramo K, Immonen I. The effect of pregnancy on mild diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 1997; 235: 437-41.
106. Loukovaara S, Haiju M, Kaaja R, Immonen I. Retinal capillary blood flow in diabetic and non-diabetic women during pregnancy and postpartum period. Invest Ophthalmol Vis Sci 2003; 44: 1486-1491.
107. Desoye G, Shafrir E. The human placenta in diabetic pregnancy. Diabetes Rev 1996; 4: 70-89.
108. Reis F, D'Antona D, Petraglia F. Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr Rev 2002; 23: 230-57.
109. Frankenne F, Closset J, Gomez F, Scippo ML, Smal J, Hennen G. The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J Clin Endocrinol Metab 1988; 66: 1171-80.
110. Larinkari J, Laatikainen L, Ranta, T, Mörönen P, Pesonen K, Laatikainen T. Metabolic control and serum hormone levels in relation to retinopathy in diabetic pregnancy. Diabetologia 1982; 22: 327-32.
111. Caufriez A, Frankenne F, Englert Y, et al. Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy. Am J Physiol 1990; 258: E1014-E1019.
112. Merimee TJ. Diabetic retinopathy: a synthesis of perspectives. N Engl J Med 1990; 322: 979-83.
113. Bhaumick B, Danilkewich AD, Bala RM. Insulin-like growth factors (IGF) I and II in diabetic pregnancy: suppression of normal pregnancy-induced rise of IGF-I. Diabetologia 1986; 29: 792-97.
114. Klein BEK, Moss SE, Klein R. Is menarche associated with diabetic retinopathy? Diabetes Care 1990; 13: 1034-38.b.
115. Chantelau E. Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy. Br J Ophthalmol 1998; 82: 725-30.
116. Lauszus F, Klebe JG, Bek T, Flyvbjerg A. Increased serum IGF-I during pregnancy is associated with progression of diabetic retinopathy. Diabetes 2003; 52: 852-56.
117. Forrester JV, Shafiee A, Schroder S, Knott R, McIntosh L. The role of growth factors in proliferative diabetic retinopathy. Eye 1993; 7: 276-87.
118. Forrester JV, Knott RM, Olson J, Pascal M, Robertson M, Muckersie E. Growth factors and diabetic retinopathy. Diabetes Reviews International 1997; 6(1): 9-11.
119. Mathews MK Merges C, McLeod DS, Lutty GA. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Invest Ophthalmol Vis Sci 1997; 38: 2729-41.
120. Rajaram, S, Baylink DJ, Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 1997; 18: 801-31.
121. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480-87.
122. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16(1): 3-34.
123. Otani A, Tagaki H, Oh H, Koyama S, Honda Y. Angiotensin II induces expression of the Tie2 receptor ligand, Angiopoietin-2, in bovine retinal endothelial cells. Diabetes 2001; 50: 867-75.
124. Joussen AM, Poulaki V, Tsujikawa A, et al. Supression of diabetic retinopathy with angiopoetin-1. Am J Pathol 2002; 160: 1683-93.
125. Thurston G, Rudge JS, Ioffe E, et al. Angiopoetin-1 protects the adult vasculature against plasma leakage. Nat Med 2000; 6: 460-63.
126. Loukovaara S, Immonen I, Koistinen R, et al. Angiopoietic factors and retinopathy in pregnancies complicated with type 1 diabet. Diabet Med 2004; 21: 697-704.
127. Loukovaara S, Immonen I, Koistinen R, et al. The insulin-like growth factor (IGF) system and Type I diabetic retinopathy during pregnancy. J Diabet Complications 2005; 19: 297-304.
128. Loukovaara S, Immonen I, Yandle T, Nicholls G, Kaaja R. Vasoactive mediators and retinopathy during type 1 diabetic pregnancy. Acta Ophthalmol Scand 2005b; 83: 57-62.
129. Phelps RL, Sakol P, Metzger BE, Jampol LM, Freinkel N. Changes in diabetic retinopathy during pregnancy. Correlations with regulation of hyperglycemia. Arch Ophthalmol 1986; 104: 1806-10.
130. Laatikainen L, Teramo Y, Hieta-Heikurainen H, Koivisto V, Pelkonen R. A controlled study of the influence of continuous subcutaneous insulin infusion treatment on diabetic retinopathy during pregnancy. Acta Med Scand 1987; 221: 367-76.
131. Chew EY, Mills JJ, Metzger BE, et al. Metabolic control and progression of retinopathy. The diabetes in early pregnancy study. Diabetes Care 1995; 18: 631-37.
132. Löwestam-Adrian M, Agardh C-D, Åberg A, Agardh E. Preeclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in type I diabetic patients. Diabet Med 1997; 14: 1059-65.
133. Buchbinder A, Miodovnik M, McElvy S, et al. Is insulin lispro associated with the development or progression of diabetic retinopathy during pregnancy? Am J Obstet Gynecol 2000; 183: 1162-65.
134. Persson B, Swahn ML, Hjertberg R, et al. Insulin lispro therapy in pregnancies complicated by type1 diabetes meltitus. Diabetes Res Clin Pract 2002; 58: 115-21.
135. Loukovaara S, Immonen I, Teramo K, Kaaja R. Progression of retinopathy during pregnancy in type I diabetic women treated with insulin lispro. Diabetes Care 2003; 26 (4): 1193-98.
136. Masson EA, Patmore JE, Brash PD, et al. Pregnancy outcome in Type I diabetes mellitus treated with insulin lispro (Humalog). Diabet Mod 2003; 20: 46-50.
137. Jovanovic L, Ilic S, Pettin DJ, et al. Metabolic and immunologic effects of insulin Lispro in gestational diabetes. Diabetes Care 1999; 22: 1422-27.
138. Kitzmiller JL, Main E, Ward B, Theiss T, Peterson DL. Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy. Diabetes Care 1999; 22: 874-875.
139. Bhattacharyya A, Brown S, Hughes S, Vice PA. Insulin lispro and regular insulin in pregnancy. Q J Med 2001; 94:255-260.
140. Bhattacharyya A, Vice PA. Insulin lispro, pregnancy, and retinopathy (Letter). Diabetes Care 1999; 22: 2101-2102.
141. Loukovaara S, Immonen I, Teramo K, Kaaja R. Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin Lispro. Diabetes Care 2003; 26: 1193-1198.
142. Ben-Mahmud BM, Chan WH, Abdulahad RM, et al. Clinical validation of a link between TNF-alpha and the glycosylation enzyme core 2 GlcNAc-T and the relationship of this link to diabetic retinopathy. Diabetologia 2006; 49: 2185-2191.
143. Loukovaara S, Immonen I, Koistinen R, et al. Inflammatory markers and retinopathy in pregnancies complicated with type 1 diabetes. Eye 2005; 19; 422-430.
144. Ohrt V. The influence of pregnancy on diabetic retinopathy with special regard to the reversible changes shown in 100 pregnancies. Acta Ophthalmol (Copenh) 1984; 62: 603-16.
145. Axer-Siegel R, Hod M, Fink-Cohen S, et al. Diabetic retinopathy during pregnancy. Ophthalmology 1996; 103: 1815-19.
146. Sheth BP. Does pregnancy accelerate the rate of progression of diabetic retinopathy? Curr Diab Rep 2002; 2: 327-30.
147. Ferris FL, Davis MD, Aiello LM. Treatment of Diabetic Retinopathy. New Engl J Med 1999; 341: 667-78.
148. Kohner EM, Sleightholm M. Does microaneurysm count reflect severity of early diabetic retinopathy? Ophthalmology 1986; 93: 586-89.
149. Brinchmann-Hansen O, Dahl-Jorgensen K. Hanssen KF, Sandvik I. Effects of intensified insulin treatment on various lesions of diabetic retinopathy. Am J Ophthalmol 1985; 100: 644-53.
150. Jovanovic-Peterson L, Peterson CM. Diabetic retinopathy. Clin Obstet Gynecol 1991; 34: 516-25.
151. The Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabetes Care 2000; 23: 1084-91.
152. Horvat M, Maclean H, Goldberg L, Crock GW. Diabetic retinopathy in pregnancy: a 12-year prospective study. Br J Ophthalmol 1980; 64: 398-403.
153. Ayed S, Jeddi A, Daghfous F, et al. Developmental aspects of diabetic retinopathy during pregnancy. J Fr Ophthalmol 1992; 15: 474-77.
154. Lauszus F, Klebe JG, Bek T. Diabetic control in pregnancy during tight metabolic control. Acta Obstet Gynecol Scand 2000; 79: 367-70.
155. Temple RC, Aldridge VA, Sampson MJ, Greenwood RH, Heyburn PJ, Glenn A. Impact of pregnancy on the progression of diabetic retinopathy in Type 1 diabetes. Diabet Med 2001; 18: 573-77.
156. Rosenn B, Miodovnik M, Kranias G, et al. Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy. Am J Obstet Gynecol 1992; 166: 1214-18.
157. Sinclair SH, Nesler CL, Schwartz SS. Retinopathy in the pregnant diabetic. Clin Obstet Gynaecol 1985; 28: 536-52.
158. Eter N, Spitznas M. Die diabetische Retinopathie in der Schwangerschaft. Ophthalmologe 1997; 94: 689-97.
159. Lapolla A, Cardone C, Negrin P, et al. Pregnancy does not induce or worsen retinal and peripheral nerve dysfunction in insulin-dependent diabetic women. J Diabet Complications 1998; 12:74-80.
160. Hemachandra A, Ellis D, Lloyd CE, Orchard TJ. The influence of pregnancy on IDDM complications. Diabetic Care 1995; 18: 950-54.
161. Chaturvedi N, Stephenson JM, Fuller JH, the EURODIAB IDDM Complications Study Group. The relationship between pregnancy and long-term. maternal complications in the EURODIAB IDDM complications study. Diabet Med 1995; 12: 494-99.
162. Kaaja R, Sjöberg L, Hellstedt T, Immonen I, Sane T, Teramo K. Long-term effects of pregnancy on diabetic complications. Diabet Med 1996; 13: 165-69.
163. Hercules BL, Wozencroft M, Gayer M, Jeacock H. Peripheral retinal ablation in the treatrnent of proliferative diabetic retinopathy during pregnancy. Br J Ophthalmol 1980; 64: 87-93.
164. Frank RN. Diabetic retinopathy: Current concepts of evaluation and treatment. J Clin Endocrinol Metab 1986; 15: 933-69.
165. Cassar J, Hamilton AM, Kohner EM. Diabetic retinopathy in pregnancy. Int Ophthalmol Clin 1978; 18: 179-88.
166. Sinclair SH, Nesler C, Foxman B, Nichols CW, Gabbe S. Macular edema and pregnancy in insulin-dependent diabetes. Am J Ophthalmol 1984; 97: 154-67.
167. Conway M, Baldwin J, Kohner EM, Schulenburg WE, Cassar J. Postpartum progression of diabetic retinopathy. (Letters and comments) Diabetes Care 1991; 14: 1110-11.
168. American Diabetes Association. Diabetic retinopathy. Diabetes Care 2000; 23: S73-S76.
169. Dinn RB, Harris A, Marcus PS. Ocular changes in pregnancy. Obstet Gynecol Surv 2003; 58: 137-44.
170. Schultz KL, Birnbaum AD, Goldstein DA. Ocular disease in pregnancy. Curr Opin Ophthalmol 2005; 16: 308-314.
171. Soubrane G, Coscas G. Influence of pregnancy on the evolution of diabetic retinopathy. Int Ophthalmol Clin 1998; 38: 187-94.
172. Cundy T. Do all women require intensive retinal surveillance during pregnancy? Diabetes Care 2001; 24: 794-95.
173. Puza SW, Malee MP. Utilization of routine ophthalmologic examinations in pregnant diabetic patients. J Matern Fetal Med 1996; 5: 7-10.
174. Ylinen K, Aula P, Stenman U-H, Kesäniemi-Kuokkanen T, Teramo K. Risk of minor and major fetal malformations in diabetics with high heamoglobin A1c values in early pregnancy. Br Med J 1984; 289: 345-46.
175. Johnston DI. Congenital malformations in infants of diabetic mothers. Practical Diabetes International 1985; 2: 23-4.
176. Reece EA, Homko CJ. Why do diabetic women deliver malformed infants? Clin Obstet Gynecol 2000; 43(1): 32-45.
177. Suhonen L, Hiilesmaa V, Teramo K. Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia 2000; 43: 79-82.
178. American Diabetes Association. Preconception care of women with diabetes (Position Statement). Diabetes Care 2002; 25: 82S-84S.
179. The Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976; 81: 383-97.
180. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: Clinical application of Diabetic Retinopathy Study (DRS) findings. DRS report no. 8. Ophthalmology 1982; 88:583-600.
181. The Diabetic Retinopathy Vitrectomy Study Research Group. Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management: Diabetic Retinopathy Vitrectomy Study (DRVS) report #1. Ophthalmology 1985; 92: 492-502.
182. Kjos SL. Postpartum care of the women with diabetes. Clin Obstet Gynecol 2000; 43: 75-86.
183. Loukovaara S. Diabetic retinopathy and pregnancy. Medical Faculty, Helsinki University, Helsinki, Finland. http://www.ethesis.helsinki.fi